In all of these tumors a TP53 mutation was a requirement for precursor identification and in contrast to the fallopian tube, there was no consistent evidence of early or occult TP53 mutations observed within alternate sites of origin, including endosalpingosis, endometriosis, or ovarian inclusion cysts, apart from sporadic reports [33,34]. This evidence concerns the gene TP53 and endometriosis.